Inventor · disambiguated record
Hasibur Rahaman
Also filed as: RAHAMAN HASIBUR
12 granted patents·7 pending applications·7 citations·filing 2016–2024
83Inventor score
Top patents by PatentIndex Score
19 records- 0188US10669272B2Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 2, 2020·4 cites·13 claims
- 0280US2024400563A1Substituted pyridopyrimidinonyl compounds useful as t cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0378US9884868B2TGF-beta inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Feb 6, 2018·2 cites·36 claims
- 0474US2023151007A1Substituted pyridopyrimidinonyl compounds useful as t cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0567US11713316B2Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Aug 1, 2023·0 cites·11 claims
- 0666US11584747B2Substituted pyridopyrimidinonyl compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 21, 2023·0 cites·33 claims
- 0766US10336761B2TGFβ receptor antagonistBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 2, 2019·1 cites·6 claims
- 0861US10954238B1Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 23, 2021·0 cites·11 claims
- 0958US11352360B2TGF-beta inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Jun 7, 2022·0 cites·21 claims
- 1058US2024217982A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1158US2024317769A1Kras g12d inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1255US10287295B2TGF-β inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted May 14, 2019·0 cites·20 claims
- 1355US2024108654A1Combination of a t cell therapy and a dgk inhibitorJUNO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1453US12492172B2Substituted quinazolinyl compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 9, 2025·0 cites·12 claims
- 1546US10617675B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 14, 2020·0 cites·9 claims
- 1643US10961239B2TGF beta receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 30, 2021·0 cites·11 claims
- 1742US2018250303A1Tgf beta receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 1837US9981944B2GDF-8 inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·0 cites·19 claims
- 1937US2019292179A1TGF Beta RECEPTOR ANTAGONISTSBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hasibur Rahaman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →